Copertina

Differential Tumour Necrosis Factor‐Like Weak Inducer of Apoptosis ( TWEAK ) Associations in Pemphigus and Bullous Pemphigoid

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Shiran Kang, Jialu Zhao, Meixuan Li, Yumin Xia, Yale Liu
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Experimental Dermatology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Periostin in Bullous Pemphigoid: A Potential Biomarker of Disease Activity and Severity
di: Yutong Ran, et al.
Pubblicazione: (2025)

Dapagliflozin‐Associated Bullous Pemphigoid
di: Xun Feng, et al.
Pubblicazione: (2025)

Immune Checkpoint Inhibitor‐Related Bullous Pemphigoid: Distinct Clinical and Immunological Profiles
di: Min Zou, et al.
Pubblicazione: (2026)

The Secretome of Bullous Pemphigoid IgG ‐Treated Keratinocytes Induces a Pro‐Inflammatory Eosinophil Response
di: Adrian P. Mansini, et al.
Pubblicazione: (2026)

Immune Checkpoint Inhibitor–Associated Autoimmune Bullous Diseases: Beyond Bullous Pemphigoid
di: Ioannis‐Alexios Koumprentziotis, et al.
Pubblicazione: (2026)

Revisiting the Pathology of Bullous Pemphigoid: Basal Cell Necrosis as a Diagnostic Clue and Its Pathogenic Role
di: Hsuan Chen, et al.
Pubblicazione: (2025)

JAK1/2 Inhibitors Alleviate the Damage of Intercellular Adhesion by Reducing Endoplasmic Reticulum Stress‐Induced Apoptosis in Pemphigus Vulgaris
di: Xi Chen, et al.
Pubblicazione: (2025)

Involvement of Ferroptosis in Bullous Pemphigoid Pathogenesis
di: Shiling Geng, et al.
Pubblicazione: (2025)

Reassessing Ferroptosis in Bullous Pemphigoid: Methodological and Translational Considerations
di: Yang Li
Pubblicazione: (2025)

Association of Comorbid Trauma and Stressor‐Related Disorders in Pemphigus and Pemphigoid: A Case‐Control Study
di: Isabella J. Tan, et al.
Pubblicazione: (2026)

BP230 ‐Type Bullous Pemphigoid is a Rare Subset of Bullous Pemphigoid Associated With a Favorable Prognosis: A Retrospective Analysis From a Tertiary Referral Center
di: Roberto Maglie, et al.
Pubblicazione: (2025)

Optimizing Local Treatment in Pemphigus and Pemphigoid: Current Evidence and Unmet Needs
di: Roberto Maglie, et al.
Pubblicazione: (2026)

Use of Lebrikizumab in Treatment‐Refractory Bullous Pemphigoid: Two Reports
di: Christoph Zeyen, et al.
Pubblicazione: (2026)

Management of Bullous Pemphigoid in Special Populations: A Narrative Review of the Literature
di: Giulia Gasparini, et al.
Pubblicazione: (2025)

Lymphocyte Transformation Tests and Patch Tests to Identify Drugs Potentially Associated With Bullous Pemphigoid Development
di: Belen de Nicolas‐Ruanes, et al.
Pubblicazione: (2025)

A Case of Bullous Pemphigoid in a Patient With Systemic Sarcoidosis and Relapsing Polychondritis
di: Takehiro Nakamura, et al.
Pubblicazione: (2025)

Pediatric Bullous Pemphigoid Treated With Dupilumab: A Case Report With Good Response
di: Aldana Belén Almassio, et al.
Pubblicazione: (2025)

Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study
di: Gianluca Avallone, et al.
Pubblicazione: (2025)

A Case of Bullous Pemphigoid Coexisted With Psoriasis Vulgaris Successfully Treated by Apremilast
di: Haruna Kumagai, et al.
Pubblicazione: (2026)

Proteomic Analysis Reveals Oxidative Phosphorylation and JAK ‐ STAT Pathways Mediated Pathogenesis of Pemphigus Vulgaris
di: Yuqi Cheng, et al.
Pubblicazione: (2024)

Tissue Eosinophil Counts: A Promising Marker for Optimizing Omalizumab Treatment in Bullous Pemphigoid
di: Gülfem Akin, et al.
Pubblicazione: (2025)

Real‐World Evidence of Dupilumab's Efficacy in Reducing Autoantibodies to Bullous Pemphigoid Antigens
di: Kateryna Karpoff, et al.
Pubblicazione: (2026)

Dual Immune‐Related Toxicities: Secukinumab‐Induced Bullous Pemphigoid Following ICI ‐Associated Psoriasis in a Cancer Patient
di: Ioanna A. Paschou, et al.
Pubblicazione: (2025)

Epidermolysis Bullosa Acquisita due to Epitope Spreading in a Patient With Recurrent Bullous Pemphigoid
di: Athina‐Ioanna Daponte, et al.
Pubblicazione: (2025)

Lichenoid Drug Eruption due to Telmisartan–Hydrochlorothiazide Combination Progressing to Bullous Pemphigoid: A Case Report
di: Satoko Minakawa, et al.
Pubblicazione: (2025)

Correction to “The Dynamics of Circulating Tumour DNA ( ctDNA ) During Treatment Reflects Tumour Response in Advanced Melanoma Patients”
Pubblicazione: (2025)

Effect of IL‐23p19 Inhibitors for Psoriasis With Bullous Pemphigoid: Clinical Insights From Two Cases
di: Sora Sugai, et al.
Pubblicazione: (2025)

Tissue Levels of MMP‐9 and Granzyme B in Patients With Bullous Pemphigoid: A Case–Control Study
di: Hoa Dinh Pham, et al.
Pubblicazione: (2026)

Lichen Planus Pemphigoides as an Adverse Reaction to Medication Use: A Retrospective Analysis of Commonly Implicated Medication Triggers Using the FDA Adverse Events Reporting Database
di: Gaurav N. Pathak, et al.
Pubblicazione: (2025)

Association of Serum Levels of Total‐IgE and Specific antiBP180 IgE Autoantibodies With Disease Activity and Severity in Patients With Bullous Pemphigoid
di: Aikaterini Kyriakou, et al.
Pubblicazione: (2025)

Targeting Melanin Heterogeneity in Metastatic Melanoma: A Dual‐Tumour Mouse Melanoma Model
di: Marine Delmas, et al.
Pubblicazione: (2025)

Disabled 2 (Dab2) Regulates Tumour Progression in Skin Squamous Cell Carcinoma
di: Sayoni Roy, et al.
Pubblicazione: (2024)

A Case of DPP ‐4 Inhibitor‐Associated Bullous Pemphigoid With Anti‐ LAD ‐1 IgG Antibodies Arising From a Post‐Traumatic Scar
di: Momoko Sasamoto, et al.
Pubblicazione: (2025)

Precision at the Cutting Edge: Ex Vivo Confocal Microscopy for Perioperative Tumour Thickness Assessment in Melanoma
di: D. Hartmann, et al.
Pubblicazione: (2025)

Incontinence‐Associated Dermatitis‐Like Skin Changes Induced by the Application of Absorbent Pads Containing Bacteria and Artificial Urine in Rats
di: Ai Horinouchi, et al.
Pubblicazione: (2024)

Drug Repurposing of Itraconazole Suppresses Angiogenesis and Hyperplasia in Port Wine Stain via Autophagy‐Apoptosis Crosstalk
di: Lei Wang, et al.
Pubblicazione: (2026)

High ROR1 Expression Is Associated With Poor Differentiation and Perineural Invasion in Cutaneous Squamous Cell Carcinoma
di: Yannick Foerster, et al.
Pubblicazione: (2025)

PI3Kγ Deficiency Suppresses Cutaneous Squamous Cell Carcinoma Formation by Modulating the Tumour Microenvironment Rather Than by Directly Regulating Keratinocyte Proliferation
di: Aya Toyoshima, et al.
Pubblicazione: (2026)

Basophil‐Derived IL‐4 Production and Its Potential Pro‐Tumoural Role in Th2‐Polarisation Within Sentinel Lymph Nodes of Primary Cutaneous Melanoma
di: Aki Tajima, et al.
Pubblicazione: (2025)

Identification of Polyamine Metabolism‐Related Biomarkers in Psoriasis: A Study Based on Transcriptomics and Single‐Cell Sequencing
di: Li Zhang, et al.
Pubblicazione: (2026)